Cosentyx (Secukinumab)

Cosentyx (Secukinumab) is a biologic medicine that suppresses the immune system in order to treat psoriatic arthritis, ankylosing spondylitis, and psoriasis.

Cozentyx works by blocking interleukin-17 (IL-17), a signalling protein (cytokine) that regulates the immune system and is related to the body's inflammatory response.

Taking Cosentyx

Cosentyx is available as a subcutaneous (under the skin) injection.

The manufacturer of Cosentyx offers a support program to Canadian patients that are prescribed the medication:

Patient support program enrolment forms

Important Tests and Risks

Science

Safety

Resource(s)

Cosentyx Quick Reference Guide

Drug Identification Number (DIN): 02438070, 02438062